Wright Medical's Q2 net income plunges; Vayar Imaging pulls in $12M for breast cancer Dx;

 @FierceMedDev: The $3.8B deal is done. Hologic wrapped up its bid to acquire Gen-Probe. Release | Follow @FierceMedDev

 @MarkHFierce: Regulators in Singapore lowered import fees for blood pressure monitors and hearing aids. More | Follow @MarkHFierce

 @DamianFierce: Covidien has opened up its $45M R&D shop in Shanghai. News | Follow @DamianFierce

> Orthopedic devicemaker Wright Medical reported a 7% drop in sales for the second quarter, with net income tumbling to $700,000 from $6.1 million in the same period last year. Article

> Israeli startup Vayyar Imaging has raised $12 million in venture capital to fund its breast cancer diagnostics. News

> Diagnostics firm Metabolon has completed its acquisition of Lipomics, looking to combine that company's profiling lipids technology with its diabetes assay. More

> Medtronic ($MDT) CEO Omar Ishrak has taken to Twitter to spread his company's message. Story

> Smith & Nephew ($SNN), a maker of artificial hips and knees, raised its dividend 50% and will increase the payout in line with earnings growth. Story

> Baxter International ($BAX) broke ground on a new $1 billion manufacturing facility near Covington, GA. Story

Biotech News

 @FierceBiotech: RIP: After long illness, Genta finally opts to liquidate. News | Follow @FierceBiotech

 @JohnCFierce: Bristol's bad, awful, not very good day. Pensions exec charged with insider trading, via Bloomberg. And it's still early. More | Follow @JohnCFierce

 @RyanMFierce: A Google search for scientific experts? AstraZeneca adopts search engine for scientists from David Steinberg's Knode. Article | Follow @RyanMFierce

> R&D shift sees new jobs in China as Western ops are restructured. Article

> Report: Bristol exec nabbed on insider trading charge. Item

> Halozyme blitzed as FDA rejects Baxter drug, halts combo trial. Story

> Analyst reads last rites after heart failure scuttles Bristol hep C study. News

Pharma News

 @FiercePharma: Watson got FDA nod for its Pulmicort knockoff. Patent fight with AstraZeneca pending, so no launch yet. Report | Follow @FiercePharma

> Gilead inks low-cost HIV drug deal with generics makers. News

> Sanofi, Otsuka amp up their Turkish ambitions. Story

> Glass Lewis stands up for Forest's board slate. Article

Vaccines News

> Old whooping cough vax more effective than new. News

> AstraZeneca wins Fluenz contract in U.K. Article

> Survey: U.S. females fail to finish Merck and GSK HPV shots. More

> NIH awards $5M for heroin addiction, AIDS vaccine. News

> Alnylam gets $3.2M milestone from GSK for vax tech. Story

Pharma Manufacturing News 

> Hospira CEO Ball says it's getting 'gators' under control. Report

> Rexam eyes factory growth, despite lagging healthcare sales. More

> CMC nabs Xoma's Bay Area plant. Article

And Finally... More U.S. women appear to be choosing intrauterine devices for birth control, according to a national survey. Story

Suggested Articles

Seven developers will provide digital health solutions aimed at the COVID-19 pandemic, including smartphone apps, wearables and big data programs.

Illumina will drop $8 billion to reacquire its former spinout, which after nearly five years is nearing completion of its cancer-seeking blood test.

The CE Mark for the system’s fourth iteration follows a July 2019 approval from the FDA.